The World of Health & Medicine News

Danger lurks for open-water swimmers

Danger lurks for open-water swimmers

Open-water swimmers should be aware of this risk, according to researchers at the University of Manitoba in Canada:
Swimming in some stagnant lakes may lead to infection with Legionella, a bacteria that can cause pneumonia.

Legionella infection is an uncommon cause of community-acquired pneumonia that is a public health risk because it can spread through exposure to natural and man-made water bodies.

The disease manifests with fever, fatigue, symptoms of respiratory distress, and sometimes diarrhea. Legionella bacteria thrive in warm, stagnant water, plumbing systems, public spas, and even lakes and rivers.

spot_img

Explore more

spot_img

New lasso-shaped antibiotic kills drug-resistant bacteria

New lasso-shaped antibiotic kills drug-resistant bacteria Researchers at McMaster University have identified a new molecule with antibiotic activity against a range of disease-causing bacteria, including...

Chinese brain chip project speeds up human trials after first success

Chinese brain chip project speeds up human trials after first success A tie-up between a Chinese research institute and tech company said on Monday that...

Experimental drug lepodesiran reduces genetic risk factor for heart disease by...

Experimental drug lepodesiran reduces genetic risk factor for heart disease by 94 percent According to results published in the New England Journal of Medicine: In a...

Novo Nordisk to license obesity drug from Lexicon in up to...

Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal Novo Nordisk (NOVOb.CO), opens new tab is licensing Lexicon Pharmaceuticals' (LXRX.O),...

Vykat XR approved for genetic binge eating disorder

For the first time/ Vykat XR approved for genetic binge eating disorder The U.S. Food and Drug Administration (FDA) on Wednesday approved Soleno Therapeutics’ drug to...

Keytruda subcutaneous injection to launch on October 1

Keytruda subcutaneous injection to launch on October 1 Merck & Co. said Thursday it plans to launch a subcutaneous injection of its best-selling cancer immunotherapy,...

Buying an autoimmune disease drug for $1.3 billion

Sanofi/ Buying an autoimmune disease drug for $1.3 billion Sanofi announced Thursday that it has agreed to buy the biopharmaceutical company’s autoimmune disease drug Dren Bio...

US FDA approves Sanofi’s bleeding disorder therapy

US FDA approves Sanofi's bleeding disorder therapy The U.S. Food and Drug Administration approved French drugmaker Sanofi's (SASY.PA), opens new tab hemophilia therapy, introducing a new...